The RapidAI software successfully processed and identified more eligible large vessel occlusion cases vs. VizAI. It also correctly identified more LVO-negative cases and detected more LVOs missed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback